This issue of Policy Forum (Volume 3, Number 10, June 12, 2013) – How Can the FDA Encourage Social Media Use by Pharmaceutical and Medical Device Companies? – describes the extent to wh...read more
The current issue of Policy Forum (Volume 3, Number 9, May 22, 2013) – “The Medical Device Tax and Innovation: The Last Nail?” – examines the financial impact of the 2.3% me...read more
This issue of our Policy Forum (Volume 3, Number 8, April 24, 2013) — In the Aftermath of Parens Patriae: Can Private Copycats Still Sue? — explains that pharma...read more
In this issue of our Policy Forum (Volume 3, Number 5, March 13, 2013) – Out on a Limb: How Will the Prohibition of Biomedical Research Using Chimpanzees Harm Public Health? – examines ...read more
This issue of Policy Forum (Volume 3, Number 4, February 27, 2013) explains the requirements under the Patient Protection and Affordable Health Care Act’s Physician Payment Sunshine...read more
This issue of Policy Forum (Volume 3, Number 3, February 13, 2013) — "What Does the Second Circuit’s Recent Decision in United States v. Caronia Not Say?" — deconstructs the landm...read more
by Thomas N. Bulleit and Sara Kraner Policy Forum (Volume 2, Number 17, September 12, 2012) rebuts a prior issue on whether medical device companies should be owned by physicians – Why P...read more
by Joseph Truhe Volume 2, Number 10, May 23, 2012 -- In FDLI’s latest Policy Forum, Joseph Truhe, Senior Vice President and General Counsel to PDP Holdings, LLC, asks &l...read more
James M. Solyst of ENVIRON International Corporation makes the argument that, at a time when federal budgets are precarious, the private sector must be prepared to continue to contribute to the sci...read more
by Jamie Kendall and Noah Mallon The authors assert that FDA’s vagueness in the December 27, 2011-released Draft Guidance for Responding to Unsolicited Requests for Off-Label Information (&l...read more